We will evaluate the bioavailability of naproxen 500 mg administered as three dfferent formulations...
Date First Received: April 23, 2008
Last Updated: June 9, 2008
Verified by: Pozen, June 2008
Clinical Trial Phase: Phase 1 | Start Date: March 2008
Overall Status: Completed
Estimated Enrollment: 30
Brief Summary
Official Title: “An Open-Label, Randomized, 3-Way Crossover Study to Evaluate the Relative Bioavailability of a Single Oral Dose of Naproxen 500 mg Administered as PN 400 (Naproxen / Esomeprazole), as the [Active Comparator 1], or as [Active Comparator 2] in Healthy Volunteers”
Condition Keyword(s):
Intervention(s):
We will evaluate the bioavailability of naproxen 500 mg administered as three dfferent formulations.
Study Type: Interventional
Study Design: Basic Science, Randomized, Open Label, Uncontrolled, Crossover Assignment, Bio-equivalence Study
Study Primary Completion Date: June 2008
Intervention(s) in this Clinical Trial
- Drug: PN400
- naproxen 500 mg /esomeprazole 20 mg
- Drug: naproxen
- naproxen 500 mg tablet
- Drug: naproxen
- naproxen 500 mg
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: A
- PN400 (naproxen/esomeprazole)
- Active Comparator: B
- naproxen 500 mg
- Active Comparator: C
- naproxen 500 mg
Outcome Measures for this Clinical Trial
Primary Measures
- To assess and compare the pharmacokinetics and relative bioavailability of a single oral dose of naproxen 500 mg administered in 3 formulations
- Time Frame: 72-hour PK
Safety Issue?: No
- Time Frame: 72-hour PK
Secondary Measures
- To evaluate the safety of the 3 treatments
- Time Frame: entire study duration
Safety Issue?: Yes
- Time Frame: entire study duration
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Healthy male or non-pregnant female subjects between 18-55 years of age as well as other standard inclusion criteria for a study of this nature
Exclusion Criteria:
- Standard exclusion criteria for a study of this nature
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 55 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Sponsor Information
Lead Sponsor: Pozen
Additional Information
Information obtained from ClinicalTrials.gov on July 02, 2009
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00665743
Study ID Number: PN400-102
ClinicalTrials.gov Identifier: NCT00665743
Health Authority: United States: Food and Drug Administration
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.